Ann Van Gysel

Ann Van Gysel

Ann Van Gysel

CEO - flanders.healthTech

Ann Van Gysel has a PhD in biotechnology and was head of communication at VIB, the Flemish Institute for Biotechnology. She then took charge of flanders.bio and put the Flemish biotech hub on the international map with her team. Until recently, she was CEO of Turnstone Communications, a 7-member communications firm that Ann founded 10 years ago that offers services to pharmaceutical, biotech, medtech, and ICT companies, as well as a European consortium of hospitals and innovation companies committed to facilitating pediatric clinical studies. At the start of this year, she was appointed CEO of the flanders.healthTech spearhead cluster. 

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners